Candidates: Five vaccines to protect from COVID-19

Category: VAX

Types: Not specified

Status: Secretary of the Army Ryan D. McCarthy said March 19 that the U.S. Army Medical Research and Development Command and U.S. Army Medical Research Institute of Infectious Diseases were working to develop five separate COVID-19 vaccines. McCarthy said the Army had received an additional $900 million toward efforts to prevent, detect, and treat the disease.

Among the vaccine candidates is one that was already in preclinical development in animal models, Col. Wendy Sammons-Jackson, director of the Military Infectious Diseases Research Program under USAMRDC, told Stars and Stripes.


COVID-19: 200 Candidates and Counting

To navigate through the >200 potential therapeutic and vaccine options for COVID-19, GEN has grouped the candidates into four broad categories based on their developmental and (where applicable) clinical progress:

FRONT RUNNER – the most promising therapeutics/vaccines based on clinical progress, favorable data or both.

DEFINITELY MAYBE – earlier phases with promising partners, or more advanced candidates in development that have generated uneven data

KEEPING AN EYE ON… – interesting technology, attracting notable partners, or both, but preliminary data.

TOO SOON TO TELL – longshots pending additional experimental and/or clinical data.

GEN has also tagged the most common treatment types:

● ANTIVIRAL
● VAX
● ANTIBODY
● RNA

This site uses Akismet to reduce spam. Learn how your comment data is processed.